methionine has been researched along with alovudine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Dittmar, C; Galldiks, N; Garlip, G; Heiss, WD; Herholz, K; Hilker, R; Jacobs, AH; Klein, JC; Kracht, LW; Li, H; Sobesky, J; Thomas, A; Vollmar, S; Wienhard, K | 1 |
| Gault, N; Grahek, D; Gutman, F; Kerrou, K; Montravers, F; Schlienger, M; Talbot, JN; Touboul, E | 1 |
| Kanegae, K; Kohanawa, M; Kuge, Y; Seki, K; Takahashi, T; Tamaki, N; Yi, M; Zhao, S; Zhao, Y | 1 |
| Backes, H; Heiss, WD; Jacobs, AH; Kesper, K; Kracht, L; Li, H; Miletic, H; Neumaier, B; Ullrich, R; Wienhard, K | 1 |
| Hatakeyama, T; Ichikawa, T; Kawai, N; Nishiyama, Y; Sasakawa, Y; Tamiya, T; Yamamoto, Y | 1 |
| Fukumoto, D; Harada, N; Kakiuchi, T; Kamijo, A; Kawaguchi, AT; Murayama, C; Tsukada, H | 1 |
| Aboagye, EO; Al-Nahhas, A; Kenny, LM | 1 |
| Delattre, JY; Goldman, S; Petrirena, GJ | 1 |
| Hatakeyama, T; Kawai, N; Miyake, K; Okada, M; Shinomiya, A; Tamiya, T | 1 |
| Backes, H; Bjerkvig, R; Brekka, N; Hoehn, M; Jacobs, AH; Jikeli, JF; Miletic, H; Monfared, P; Neumaier, B; Niclou, SP; Stieber, D; Talasila, KM; Tavitian, B; Thorsen, F; Viel, T; Waerzeggers, Y; Wang, J; Winkeler, A | 1 |
| Boehm-Sturm, P; Hoehn, M; Jacobs, AH; Monfared, P; Neumaier, B; Rapic, S; Viel, T | 1 |
| Balkay, L; Emri, M; Goda, K; Juhász, I; Krasznai, Z; Krasznai, ZT; Lajtos, I; Márián, T; Mikecz, P; Miklovicz, T; Németh, E; Szabó, G; Szalóki, G; Trencsényi, G | 1 |
| Di Traglia, S; Galli, F; Lauri, C; Pizzichini, P; Signore, A | 1 |
| Calderoni, L; Castellucci, P; Fanti, S; Telo, S; Vichi, S; Zagni, F | 1 |
4 review(s) available for methionine and alovudine
| Article | Year |
|---|---|
[PET and malignant cerebral tumors].
Topics: Brain Neoplasms; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Glioma; Humans; Methionine; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Advances in PET imaging of brain tumors: a referring physician's perspective.
Topics: Brain Neoplasms; Carbon Radioisotopes; Dideoxynucleosides; Fluorine Radioisotopes; Glioblastoma; Glioma; Humans; Methionine; Nitroimidazoles; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2011 |
Current status of PET imaging of differentiated thyroid cancer with second generation radiopharmaceuticals.
Topics: Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iodine Radioisotopes; Methionine; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Whole Body Imaging | 2015 |
Alternative and New Radiopharmaceutical Agents for Lung Cancer.
Topics: Acetates; Carbon Radioisotopes; Dideoxynucleosides; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Lung Neoplasms; Methionine; Misonidazole; Neoplasm Staging; Neuroendocrine Tumors; Peptides; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Quinolines; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
10 other study(ies) available for methionine and alovudine
| Article | Year |
|---|---|
18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
Topics: Adult; Aged; Antiviral Agents; Astrocytoma; Biological Transport; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; False Positive Reactions; Female; Glioma; Humans; Kinetics; Magnetic Resonance Imaging; Male; Medulloblastoma; Methionine; Middle Aged; Phosphorylation; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors | 2005 |
Usefulness of 11C-methionine for differentiating tumors from granulomas in experimental rat models: a comparison with 18F-FDG and 18F-FLT.
Topics: Animals; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell Line, Tumor; Diagnosis, Differential; Dideoxynucleosides; Fluorodeoxyglucose F18; Granuloma; Inflammation; Liver Neoplasms; Male; Methionine; Mycobacterium bovis; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Turpentine | 2008 |
Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma.
Topics: Adult; Aged; Brain Neoplasms; Carbon Radioisotopes; Cell Proliferation; Dideoxynucleosides; Female; Fluorine Radioisotopes; Glioma; Humans; Immunohistochemistry; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2008 |
11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Cell Proliferation; Child; Child, Preschool; Dideoxynucleosides; Female; Glioma; Humans; Immunohistochemistry; Male; Methionine; Middle Aged; Positron-Emission Tomography | 2008 |
Evaluation of D-18F-FMT, 18F-FDG, L-11C-MET, and 18F-FLT for monitoring the response of tumors to radiotherapy in mice.
Topics: Animals; Carbon Radioisotopes; Carcinoma, Squamous Cell; Cell Line, Tumor; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Methionine; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Positron-Emission Tomography; Tyrosine | 2009 |
Novel PET biomarkers for breast cancer imaging.
Topics: Biomarkers, Tumor; Breast Neoplasms; Dideoxynucleosides; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Methionine; Positron-Emission Tomography | 2011 |
Usefulness of FDG, MET and FLT-PET studies for the management of human gliomas.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Glioma; Humans; Linear Models; Male; Methionine; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Statistics, Nonparametric | 2012 |
Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multimodal small-animal PET and MRI.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Data Interpretation, Statistical; Dideoxynucleosides; Disease Progression; Fluorodeoxyglucose F18; Glioblastoma; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Ki-67 Antigen; Magnetic Resonance Imaging; Methionine; Neoplasm Transplantation; Neovascularization, Pathologic; Paraffin Embedding; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude; Xenograft Model Antitumor Assays | 2012 |
Non-invasive imaging of glioma vessel size and densities in correlation with tumour cell proliferation by small animal PET and MRI.
Topics: Animals; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Glioblastoma; Humans; Magnetic Resonance Imaging; Methionine; Neoplasm Transplantation; Neovascularization, Pathologic; Positron-Emission Tomography; Rats; Rats, Nude | 2013 |
18FDG, [18F]FLT, [18F]FAZA, and 11C-methionine are suitable tracers for the diagnosis and in vivo follow-up of the efficacy of chemotherapy by miniPET in both multidrug resistant and sensitive human gynecologic tumor xenografts.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autoradiography; Carbon Radioisotopes; Cell Line, Tumor; Dideoxynucleosides; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Flow Cytometry; Fluorodeoxyglucose F18; Follow-Up Studies; Genital Neoplasms, Female; Humans; Methionine; Mice; Mice, SCID; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |